UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: pharmaceuticals

How do we build the solutions that will transform healthcare’s future?

We are building the solutions that will revolutionise healthcare in the future: solutions that will transform the trust relationship between the industry and patients, and the whole dynamic of healthcare. As co-founder of 23 Consulting, I am involved in supporting health organisations with their blockchain projects.

Read More

Empowering patients: creating a healthcare data Blockchain network

Alongside my primary role as a Project Manager, I have since 2016 been the Roche lead for the IMI industry collaboration called EHR4CR. EHR4CR is a group of roughly 10 pharma companies, universities, and SMEs working together to leverage the great wealth of information from hospitals in order to support our clinical trials and promote innovative research. It was a 7-year $16 million project.

Read More

Predicting future threats by approaching CyberSecurity from all angles

Merck, Sharp & Dohme operates a hub model with IT hubs in the US, Czech Republic, and Singapore.

All operations and important functions of IT are distributed within those three hubs. It ensures not only that we follow the standard model but also ensures the regional presence and cooperation with the sites in any region.

Read More

Accelerating the Medicinal Chemistry Design Cycle

MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden interviewed Emma Parmee from Merck & Co at the Global Medicinal Chemistry and GPCR Summit.

Read More

Optimising Targeted Protein Degradation

02MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden interviewed George Burslem from Yale University at the Global Medicinal Chemistry and GPCR Summit.

Read More

Insights in Medicinal Chemistry and GPCR

MedChemNet and Future Medicinal Chemistry editors Jasmine Harris and Ben Walden share 5 key insights gained from the Global Medicinal Chemistry and GPCR Summit.

Read More

The Microbiome Represents a Paradigm Shift for European Pharmaceutical Regulators

Recent microbiome research has demonstrated the important role that these communities of microorganisms play on human homeostasis. The gut microbiome is being thoroughly studied, and other microbiomes are now becoming the focus of greater attention, as well as other organs of the host, due to the concept of ‘axes,’ such as the gut-brain axis, gut-lung axis, gut-liver axis.

Read More

Reviewing the Global Medicinal Chemistry and GPCR Summit

MedChemNet and Future Medicinal Chemistry were thrilled to attend the Global Medicinal Chemistry and GPCR Summit, organised by Global Engage. The event shared the latest in medicinal chemistry and GPCR developments with delegates from across the globe. Represented at the summit were a number of large and small pharmaceutical companies, as well as biotechnology companies, CROs and academics.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive